Today, Rep Allen sent a letter (attached) to the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee in response to their recent June 28th meeting to consider the process for COVID vaccine variants. He also released the following statement:
“It is crucially important for the FDA to safeguard Americans through its appointed role of oversight. Now that we are no longer in a state of emergency, and with no legal liability for vaccine makers, it is important that we carefully scrutinize vaccine variations. This is the time to slow down and do careful research. Political pressure and pressure from Big Pharma should not lead the FDA to cut corners.”